S4 E5: ASCO 2026 Special Part 2
ASCO Special Part 2: Quick Bite Marathon! The Oncology Journal Club Podcast hosted by Professor…
Browsing: ASCO
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
The report “Lancet Oncology Commission on Cancer Workforce: A Global Crisis” was launched at the…
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
The CAPTURE breast cancer clinical trial has concluded that current standard of care, chemotherapy with…
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
Patients with relapsed multiple myeloma treated with the immunotherapy teclistamab lived significantly longer and remained…
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
The report “Lancet Oncology Commission on Cancer Workforce: A Global Crisis” was launched at the…
ASCO 2026: Digital symptom monitoring with nurse support helps maintain quality of life in advanced cancer
A digital symptom monitoring program supported by palliative care nurses helped maintain quality of life…
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
Patients with relapsed multiple myeloma treated with the immunotherapy teclistamab lived significantly longer and remained…
ASCO 2026: EMERALD-3 study shows that new combination treatment strategies for embolization-eligible hepatocellular carcinoma are superior
Results from the Phase 3 EMERALD-3 study found that combining the standard treatment of transarterial…
ASCO 2026: Selpercatinib shows decrease in risk of disease recurrence or death as adjuvant therapy for early-stage RET fusion-positive NSCLC
Adjuvant treatment with the targeted therapy drug selpercatinib can help reduce the risk that cancer…
ASCO 2026: More accessible oral chemotherapy and ultra-low-dose immunotherapy combo may improve survival and reduce side effects for advanced head and neck cancer
Results from a new study out of India found that triple oral metronomic chemotherapy combined…